Financials for the IBO Laboratory Instrument Sales Index have been updated from the numbers that appeared in the February 15 issue. For the fourth quarter 2013, Index sales grew 7.7%, 6.9% excluding currency, to $7,022 million. Operating profit climbed 14.0% to $1,624, and operating margin improved 130 basis points to 19.1% of sales. For 2013, […]
Bagneux, France 3/4/14; Paris, France 3/20/14—Genomic Vision, a developer of DNA molecular combing technology, has announced that it plans to list on the Euronext Paris stock exchange. The company’s technology provides a panoramic view of large regions of the genome, including detection of structural variations, and allows the direct visualization of genetic anomalies. The company […]
Cambridge, UK 3/24/14 Cambridge, UK 3/27/14—Gene editing technology firm Horizon Discovery has raised £68.6 million ($113.1 million = £0.61 = $1) in its IPO, resulting in gross proceeds of £40 million ($66 million), prior to listing its shares on the UK’s AIM stock exchange on March 27 (see IBO 2/28/14). The firm started trading at […]
The US equity markets rallied on the final trading day of March as the Federal Reserve stated a further commitment to support economic growth. Earlier in the month, the Fed reduced its monthly bond purchases by another $10 billion to $55 billion as expected, but instigated concerns over rising interest rates after eliminating the unemployment […]
Fourth quarter 2013 IBO Life Science Index sales grew 6.2%, 8.7% organically, to $4,025 million. Operating profit jumped 14.9% to $970 million due to strong performances from Illumina and Merck Millipore. Operating margin expanded 150 basis points to 20.5% of sales. Full-year 2013 Life Science Index sales improved 3.1%, 5.2% organically, to $13,956 million. Operating […]
Company Announcements German distributor Altmann Analytik acquired Dinkelberg analytics in January. Techcomp announced in January that it will acquire the remaining 49% equity interest in Jingke Scientific, a Chinese instrument manufacturer, and 51% equity interest in Jingke Trading from INESA Electron for $2.1 million. The Jingke companies had 2012 sales of $10.2 million. Agilent Technologies […]
NanoString Technologies and Luminex also exceeded fourth quarter 2013 adjusted EPS estimates. On February 26, NanoString projected 2014 sales to grow 43%–59% to $45–$50 million with a net operating loss of $40–$50 million. Shares climbed 2.7% the next day. On February 3, Luminex projected 2014 sales to grow 5%–12% to $225–$240 million, in line with […]
Cambridge, UK 2/27/14—Horizon Discovery plans to raise £25 million ($42 million = £0.60 = $1) through an IPO on the London Stock Exchange’s AIM market. Horizon supplies the GENESIS gene editing and X MAN cell line platforms for genomics research and the development of personalized medicines. In 2013, Horizon revenues grew more than 70% to […]
Despite continued weakness in industrial markets, revenues for six major publicly traded analytical instrument and lab product businesses grew in the most recently ended quarter, benefitting in part from year-end budget releases and strength in Europe. Sales also climbed for each of the five businesses with fiscal years ending during the period 2013, despite weaker […]
With only nine of the 16 companies in the IBO Laboratory Instrument Index reporting quarterly results before this issue’s publication, IBO estimates fourth quarter 2013 sales improved roughly 7%, or 6% excluding currency. The jump in growth was a result of strong results from Illumina and Waters, as well as the combined Agilent Technologies Life […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
